ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
9ÔÂ12ÈÕ-14ÈÕ£¬µÚÈý½ì¹ú¼ÊÉúÎïÒ½Ò©¹¤ÒµÉú³¤´ó»á½«ÔÚÉϺ£ÄϽ¼±ö¹Ý¾ÙÐС£´ó»á½«Í¨¹ýÖ÷Ìⱨ¸æ¡¢Ô²×À¶Ô»°µÈ½»Á÷ÐÎʽ£¬Ì½ÌÖÁ¢ÒìÒ©Îï·¢Ã÷¡¢¿¹Ìå¡¢ÒßÃçÓëÉúÎïÖÎÁÆÐÂÁÆ·¨¡¢¿¹Ö×ÁöÕïÁƵÄÐÂÕ½ÂÔºÍÐÂÊÖÒÕ¡¢ÂѰ×Öʼ°¶àëÄÊÖÒÕÇ°ÑØÓ빤ҵӦÓá¢ÌÇÄò²¡¼°·ÊÅÖ´úл¼²²¡ÕïÖÎÐÂÊÖÒÕºÍÐÂÁÆ·¨¡¢ÐÂÐÍÃ¸ÖÆ¼ÁµÄ´´ÔìÓ빤ҵ»¯µÈÐÐÒµÈÈÃÅ»°Ìâ¡£
×ðÁú¿Ê±×÷Ϊ±¾½ì´ó»áµÄа쵥룬½«·ºÆðÓ¢²Å¡°É½º£»á¡±Ô²×ÀÂÛ̳¡£±ðµÄ£¬×ðÁú¿Ê±×¨¼Ò½«ÔÚÖ÷ÂÛ̳¼°×¨Ìâ·ÖÂÛ̳ÉÏ´øÀ´¾«²Ê·ÖÏí£¬Ï£Íûͨ¹ý´Ë´ÎÔ˶¯½øÒ»²½¼ÓÉî×ðÁú¿Ê±ÓëÒ½Ò©ÐÐÒµÊ×ÄÔ¡¢×¨¼ÒѧÕß¼äµÄ½»Á÷£¬·ÖÏí×ðÁú¿Ê±×îÐÂÊÖÒÕÆ½Ì¨ºÍÒ»Ö±¾«½øµÄÁÙ´²Ç°Ñз¢Ð§ÀÍÄÜÁ¦¡£
ÎÒÃǽ«È«³ÌÔÚB5ÉèÕ¹£¬³ÏÑûݰÁÙ½»Á÷£¡
¾Û»áËùÔÚ£ºÉϺ£ÄϽ¼±ö¹Ý£¨·îÏÍÇøÍû԰·8ºÅ£©
×ðÁú¿Ê±×÷Ϊ±¾½ì´ó»áµÄа쵥룬½«·ºÆðÓ¢²Å¡°É½º£»á¡±Ô²×ÀÂÛ̳£¬×ðÁú¿Ê±Ê×ϯ¿ÆÑ§¹ÙÅíË«Çå½ÌÊÚÁªºÏÖ÷³Ö£¬Ê×ϯÉÌÎñ¹Ù²Ì½ðÄȲ©Ê¿³öϯ¶Ô»°£¬²¢Ô¼ÇëÀ´×ÔѧÊõ½ç¡¢¹¤Òµ½çºÍͶ×ʽçµÄ¶¥¼âר¼Ò·ÖÏí¿´·¨ºÍÂÄÀú¡£
ʱ¼ä£º9ÔÂ13ÈÕ 08:30-11:50
ËùÔÚ£ºÒ»Â¥·ïÑôÐù
Éϰ볡£º08:30-10:15
Ö÷³ÖÈË£ºÐì¾ü£¬ÃÀ¹úBIORICH¹«Ë¾¶Ê³¤
²Î»á¼Î±ö£º
ÕÅÐ÷Ä£¬ÄÏ·½¿Æ¼¼´óѧƺɽÉúÎïÒ½Ò©Ñо¿ÔºÔº³¤
Ф¹ðɽ£¬ÉîÛÚδÀ¶×ª»¯Ò½Ñ§Ñо¿ÔºÔº³¤
ÕÅÒúÉú£¬ÎÞÎý±´ËþÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾Ê×ϯ¿Æ¼¼¹Ù
÷µÂÊ¢£¬ËÕÖݹú¿ïÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾¶Ê³¤
Ê¢¾Õ»¨£¬º£Õ飨ÉϺ££©ÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾¶Ê³¤
ÐìºìÑÒ£¬¼ª¶ûÉú»¯£¨ÉϺ££©ÓÐÏÞ¹«Ë¾¶Ê³¤
ÏÄ Ñô£¬±±¾©Ôªº½×ÊÔ´ºÏ×ÊÈË
ÕŻݱó£¬ÖйúÒ©¿Æ´óѧ½ÌÊÚ
ÇñÇàËÉ£¬¸ßÄÜ×ÊÔ´¸±×ܲÃ
÷Ïþµ¤£¬°Ù°ÂÌ©¼¯ÍŶʳ¤
»ÆÔ¾½ø£¬ÉϺ£èîÃÉÉúÎïÊÖÒÕÓÐÏÞ¹«Ë¾¶Ê³¤
×ÞÖ¾ÑÖйúÈ«Çò¿µ½¡Ò©ÎïÑз¢ÖÐÐÄÖ÷ÈÎ
ϰ볡£º10:30-11:50
Ö÷³ÖÈË£ºÅíË«Ç壬×ðÁú¿Ê±Ê×ϯ¿ÆÑ§¹Ù
²Î»á¼Î±ö£º
×ÞÁéÁú£¬ËÕÖÝ¿µÎ¬Ñ¶ÉúÎïÊÖÒնʳ¤
Âí¿ª¹ú£¬ÀÊ»ªÖÆÒ©CEO£»Î¬ÑÇÉúÎï¸ß¼¶¸±×ܲÃ
Íõ ´Ô£¬Âõ½Üת»¯Ò½Ñ§Ñо¿£¨ËÕÖÝ£©ÓÐÏÞ¹«Ë¾¸ß¼¶¸±×ܲÃ
²Ì½ðÄÈ£¬ÉϺ£×ðÁú¿Ê±ÉúÎïÒ½Ò©ÓÐÏÞ¹«Ë¾Ê×ϯÉÌÎñ¹Ù
ÁõÃÏÔª£¬Á¢ÔªÉúÎïÒ½Ò©ÊÖÒÕÓÐÏÞ¹«Ë¾£¬¶Ê³¤¼æCEO
κ¼ÌÒµ£¬ËÕÖÝΩÓÓ»ùÒòÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾¶Ê³¤
Ç® êÍ£¬½ËÕ´óѧҽѧԺ½ÌÊÚ
Áº Íþ£¬ÉϺ£ÓòÔÆÒ½ÁÆ¿µ½¡¿Æ¼¼ÓÐÏÞ¹«Ë¾Ê×´´ÈË¡¢CEO
ÂíÐËÔª£¬»ª¶«Àí¹¤´óѧ½ÌÊÚ
ÕÅÑ϶¬£¬ÉîÛÚ¿ªÔÃÉúÃü¿Æ¼¼ÓÐÏÞ¹«Ë¾Ê×ϯ¿ÆÑ§¹Ù
³Âº£Ï¼£¬Ìì½ò´óѧҩÎï¿ÆÑ§ÓëÊÖÒÕѧԺ½ÌÊÚ
ÑÌΣ¬ÄÏ·½¿Æ¼¼´óѧϸ°ûÓë»ùÒòÖÎÁÆÑо¿ÖÐÐĽÌÊÚ£»Èðôà°ÂÄÉ£¨ÉîÛÚ£©ÉúÎïÒ½Ò©ÓÐÏÞ¹«Ë¾Ê×´´ÈË
ÅíË«Çå ½ÌÊÚ ×ðÁú¿Ê±Ê×ϯ¿ÆÑ§¹Ù
±±¾©´óѧԤ·Àҽѧ²©Ê¿ºó¡¢Öйú¶¾Àíѧ»á¸±Àíʳ¤¡¢ÃÀ¹úÃÜÎ÷¸ùÖÝÁ¢´óѧҩÀíѧ²©Ê¿ºó¡£ºã¾Ã´ÓÊÂÐÂÒ©´´ÔìÁÙ´²Ç°Ñо¿£¬¼ç¸ºGLPÊÖÒÕÆ½Ì¨½¨Éè¡£½ÒÏþ¿ÆÑÐÂÛÎÄ300ÓàÆª£¨SCIÂÛÎÄ100ÓàÆª£©£¬Ö÷±à²Î±à׍ָ13²¿¡£»ñÊ¡²¿¼¶¿Æ¼¼½±12Ï»ñÖйú¿ÆÐ¡°ÌìÏÂÓÅÒì¿Æ¼¼ÊÂÇéÕß¡±ÉùÓþ³Æºô¡¢Öйú¶¾ÀíѧÓÅÒìТ˳½±¡£×÷Óý˶ʿ¡¢²©Ê¿¼°²©Ê¿ºó90¶àÃû¡£¼æÈÎʳÎïÒ©Æ·¼àÊÓÖÎÀí¾ÖÐÂÒ©ÉóÆÀר¼Ò¡¢Ò½ÁÆÆ÷еÉóÆÀר¼Ò¡¢»·±£²¿ÐÂÎïÖÊÉóÆÀר¼Ò¼°ETAP¸±Ö÷±àµÈѧÊõÖ°Îñ¡£
¶Ô»°Ö÷Ì⣺The Future of Biopharma: Navigating Innovation, Regulation, and Global Collaboration
ËùÔÚ£º һ¥»ª²ýÌü Ö÷ÂÛ̳
ʱ¼ä£º 9ÔÂ12ÈÕ 12:00-12:30
Íõµ¤ ²©Ê¿ ×ðÁú¿Ê±ÐÂÒ©×¢²á²¿×ܼà&ÖÆ¼Á²¿¸ß¼¶Ö÷ÈÎ
Íõµ¤£¬ÉòÑôÒ©¿Æ´óѧ±¾¿Æ£¬ÉϺ£½»Í¨´óѧ˶ʿ£¬¸´µ©´óѧ²©Ê¿£¬ÔÚÒ©ÆóÓÐÊ®ÓàÄêÑз¢ÂÄÀú£¬ÔøÏòµ¼ÍŶÓ×éÖ¯¹ý¶à¸öÏîÄ¿µÄ×¢²áÉ걨£¬ÊìϤÐÂÒ©CMCºÍÁÙ´²Ç°ÆÀ¼ÛÀú³Ì£¬ÒÔ¼°Ò©ÎïµÄÁÙ´²ÆÀ¼ÛÀú³Ì£¬ÄÜÔÚÁ¢ÒìÒ©×¢²áÉ걨սÂÔÒÔ¼°Ò©Î↑·¢Ê±´ú£¬Ìṩ¸üºÃµÄ¹æÔòºÍÊÖÒÕÖ§³Ö¡£
·ÖÏíÖ÷Ì⣺BL-602, A Cyclophilin Inhibitor, Reduces Fibrosis and Proteinuria in Chronic Kidney Disease
ËùÔÚ£º һ¥»ª²ýÌü Ö÷ÂÛ̳
ʱ¼ä£º 9ÔÂ12ÈÕ 11:35-11:55
Ô¬ÔÆÔÆ ²©Ê¿ ×ðÁú¿Ê±Ò©Ð§²¿ÏîĿ˾Àí
ÉϺ£ÖÐÒ½Ò©´óѧ²©Ê¿£¬Ö÷Òª´ÓÊ·ÇÖ×ÁöÒ©ÎïµÄÁÙ´²Ç°ÌåÄÚҩЧѧÆÀ¼ÛÊÂÇ飬Ñо¿ÄÚÈݰüÀ¨´úлÐÔ¼²²¡¡¢ÄÔ×äÖС¢¾«Éñ¼²²¡ÒÔ¼°Ñ×Ö¢ÃâÒßÀ༲²¡µÄ¶¯ÎïÌåÄÚҩЧѧ¼°Ò©Àí»úÖÆÑо¿¡£ÏÖÔÚÔÚ×ðÁú¿Ê±Ñз¢Æ½Ì¨¼ÓÈë²¢Íê³É°ÙÓàÏîÏà¹ØÐÂÒ©Ñз¢ÏîÄ¿£¬ËùÈÏÕæµÄ¶à¸öÏîÄ¿ÒÑÍê³Éº£ÄÚÍâINDÉ걨¡£
·ÖÏíÖ÷Ì⣺Animal Models of Human Diseases and the Application in Pharmacodynamic Studies
ËùÔÚ£º һ¥¾Û»áÊÒ5B IDDST02-¼²²¡Ä£×ÓÓëÓ¦ÓÃ
ʱ¼ä£º 9ÔÂ12ÈÕ 14:05-14:30
ÈçÄúÏ£ÍûÔÚÏÖ³¡Óë×ðÁú¿Ê±×¨¼ÒÅöÃæ
½Ó´ýÁªÏµ×ðÁú¿Ê±Ô¤Ô¼°²ÅÅ
ɨÂëÔÚÏßÁªÏµ
ÁªÏµÓÊÏ䣺marketing@medicilon.com.cn